-
EP1667993
European procedure
Extract from the Register of European Patents
EP About this file: EP1667993
| EP1667993 - HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.05.2016 Database last updated on 29.06.2024 | Most recent event Tooltip | 06.05.2016 | No opposition filed within time limit | published on 08.06.2016 [2016/23] | Applicant(s) | For all designated states AbbVie Deutschland GmbH & Co KG Max-Planck-Ring 2a 65205 Wiesbaden / DE | [2015/21] |
| Former [2006/24] | For all designated states Abbott GmbH & Co. KG Max-Planck-Ring 2 65205 Wiesbaden / DE | Inventor(s) | 01 /
LUBISCH, Wilfried Hausserstrasse 15 69115 Heidelberg / DE | 02 /
HORNBERGER, Wilfried Goldener Winkel 14 67434 Neustadt / DE | 03 /
OOST, Thorsten, K. Gaisbergstrasse 21 69115 Heidelberg / DE | 04 /
SAUER, Daryl, Richard 23619 112th Street Trevor, WI 53179 / US | 05 /
UNGER, Liliane Wollstrasse 129 67065 Ludwigshafen / DE | 06 /
WERNET, Wolfgang Freiheitstrasse 73 67434 Neustadt / DE | 07 /
GENESTE, Hervé Rehbachstr. 42 67141 Neuhofen / DE | [2006/25] |
| Former [2006/24] | 01 /
LUBISCH, Wilfried Hausserstrasse 15 69115 Heidelberg / DE | ||
| 02 /
HORNBERGER, Wilfried Goldener Winkel 14 67434 Neustadt / DE | |||
| 03 /
OOST, Thorsten, K. Gaisbergstrasse 21 69115 Heidelberg / DE | |||
| 04 /
SAUER, Daryl, Richard 23619 112th Street Trevor, WI 53179 / US | |||
| 05 /
UNGER, Liliane Wollstrasse 129 67065 Ludwigshafen / DE | |||
| 06 /
WERNET, Wolfgang Freiheitstrasse 73 67434 Neustadt / DE | Representative(s) | Reitstötter Kinzebach Patentanwälte Postfach 21 11 60 67011 Ludwigshafen / DE | [2015/27] |
| Former [2014/10] | Reitstötter - Kinzebach Patentanwälte Postfach 21 11 60 67011 Ludwigshafen / DE | ||
| Former [2007/40] | Pohl, Michael Friedrich, et al Reitstötter, Kinzebach & Partner (GbR) Patentanwälte Postfach 21 11 60 67011 Ludwigshafen / DE | ||
| Former [2006/24] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | Application number, filing date | 04765719.2 | 30.09.2004 | [2006/24] | WO2004EP10940 | Priority number, date | US20030675300 | 30.09.2003 Original published format: US 675300 | [2006/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005030755 | Date: | 07.04.2005 | Language: | EN | [2005/14] | Type: | A1 Application with search report | No.: | EP1667993 | Date: | 14.06.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.04.2005 takes the place of the publication of the European patent application. | [2006/24] | Type: | B1 Patent specification | No.: | EP1667993 | Date: | 01.07.2015 | Language: | EN | [2015/27] | Search report(s) | International search report - published on: | EP | 07.04.2005 | Classification | IPC: | C07D401/14, C07D409/04, C07D417/14, C07D413/14, A61K31/404, A61P25/00 | [2006/24] | CPC: |
C07D401/14 (EP,US);
A61P1/14 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P25/32 (EP);
A61P43/00 (EP);
A61P5/06 (EP);
A61P5/38 (EP);
C07D401/12 (EP,US);
C07D403/14 (EP,US);
C07D405/14 (EP,US);
C07D409/04 (EP,US);
C07D409/14 (EP,US);
C07D413/14 (EP,US);
C07D417/14 (EP,US);
C07D513/04 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2015/27] |
| Former [2006/24] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Extension states | HR | 10.03.2006 | LT | 10.03.2006 | LV | 10.03.2006 | Title | German: | HETEROARYLSUBSTITUIERTE 1,3-DIHYDROINDOL-2-ONDERIVATE UND DIESE ENTHALTENDE MEDIKAMENTE | [2006/24] | English: | HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM | [2006/24] | French: | DERIVES DE 1,3-DIHYDROINDOL-2-ONE SUBSTITUES PAR HETEROARYLE ET MEDICAMENTS RENFERMANT CEUX-CI | [2014/46] |
| Former [2006/24] | DERIVES HETEROARYLE-SUBSTITUES DE 1,3-DIHYDROINDOL-2-ONE ET MEDICAMENTS RENFERMANT CEUX-CI | Entry into regional phase | 10.03.2006 | National basic fee paid | 10.03.2006 | Designation fee(s) paid | 10.03.2006 | Examination fee paid | Examination procedure | 10.03.2006 | Examination requested [2006/24] | 19.07.2010 | Despatch of a communication from the examining division (Time limit: M08) | 28.03.2011 | Reply to a communication from the examining division | 21.12.2012 | Despatch of a communication from the examining division (Time limit: M06) | 06.06.2013 | Reply to a communication from the examining division | 08.10.2013 | Communication of intention to grant the patent | 17.02.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 27.02.2014 | Communication of intention to grant the patent | 08.07.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 01.09.2014 | Communication of intention to grant the patent | 30.12.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.02.2015 | Communication of intention to grant the patent | 15.05.2015 | Fee for grant paid | 15.05.2015 | Fee for publishing/printing paid | 15.05.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP12177640.5 / EP2546250 | EP12177642.1 / EP2546251 | EP12177644.7 / EP2546252 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.07.2010 | Opposition(s) | 04.04.2016 | No opposition filed within time limit [2016/23] | Fees paid | Renewal fee | 08.09.2006 | Renewal fee patent year 03 | 05.09.2007 | Renewal fee patent year 04 | 27.03.2008 | Renewal fee patent year 05 | 04.09.2009 | Renewal fee patent year 06 | 07.09.2010 | Renewal fee patent year 07 | 08.09.2011 | Renewal fee patent year 08 | 26.09.2012 | Renewal fee patent year 09 | 09.09.2013 | Renewal fee patent year 10 | 08.09.2014 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DY]WO9315051 (SANOFI ELF [FR]) [DY] 1-17* example -; table 3 *; | [YD]WO9518105 (SANOFI SA [FR], et al) [YD] 1-17 * example -; tables II,III,IV *; | [Y]WO03008407 (SANOFI SYNTHELABO [FR], et al) [Y] 1-17 * example -; table 2 * | by applicant | - Fortschritte der Arzneimittelforschung, BIRKHäSER VERLAG., (1966), vol. 10, pages 224 - 285 |